Bortezomib Recruiting Phase 2 / 3 Trials for Acute Lymphoblastic Leukaemias (ALL) / Acute Lymphoblastic Lymphoma Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2 / 3
clinicaltrials.gov IdentifierTitleDrugs
NCT03590171International Study for Treatment of High Risk Childhood Relapsed ALL 2010